Clinical Trial Update: Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating Nyxol eye drops as a single agent and in combination with low-dose pilocarpine for presbyopia. The study is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• Nyxol Eye Drops
• Pilocarpine Eye Drops (low-dose) (pilocarpine)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED | Results posted: 2025-06-03